Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Pain D010146 64 associated lipids
Abscess D000038 13 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Alzheimer Disease D000544 76 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Kenny MT et al. Comparative effect of the naphthalenic ansamycins rifamycin SV, rifampin and cyclopentylrifampicin on murine neutrophil function. 1989 Int. J. Immunopharmacol. pmid:2559042
Ward TJ et al. Enantiomeric resolution using the macrocyclic antibiotics rifamycin B and rifamycin SV as chiral selectors for capillary electrophoresis. 1995 J Chromatogr A pmid:8520671
Kockar F et al. Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro. 2010 J Enzyme Inhib Med Chem pmid:20429781
Li W et al. Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography. 2015 J Pharm Biomed Anal pmid:26103526
Sarr FS et al. A novel biochromatographic Oatp2 column to study the transmembrane transport of statins. 2010 J Pharm Biomed Anal pmid:20045601
Magnan A et al. Anaphylactic reaction to rifamycin SV: presence of specific IgE antibodies. 1999 J. Allergy Clin. Immunol. pmid:10329836
Cardot E et al. Anaphylactic reaction to local administration of rifamycin SV. 1995 J. Allergy Clin. Immunol. pmid:7529781
Torbeev V et al. Substitution of proline32 by α-methylproline preorganizes β2-microglobulin for oligomerization but not for aggregation into amyloids. 2015 J. Am. Chem. Soc. pmid:25633201
Ghisalba O et al. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. 1982 J. Antibiot. pmid:7200089
Xiao-Chang F et al. Biochemical study of R-75-1, a new semi-synthetic rifamycin. 1981 J. Antibiot. pmid:6168632
Brufani M et al. The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. 1984 J. Antibiot. pmid:6526730
Wondrak EM et al. Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs. 1988 J. Antimicrob. Chemother. pmid:2452149
Dylan T et al. Hypoosmotic adaptation in Rhizobium meliloti requires beta-(1----2)-glucan. 1990 J. Bacteriol. pmid:1689716
Erickson RJ and Grosch JC Isolation and characterization of a polynucleotide phosphorylase from Bacillus amyloliquefaciens. 1977 J. Bacteriol. pmid:45489
Abu-Shady MR et al. Studies of rifamycin production by Amycolatopsis mediterranei cells immobilized on glass wool. 1995 J. Basic Microbiol. pmid:8568638
Babasaki K et al. Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. 1985 J. Biochem. pmid:3936839
Kono Y Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. 1982 J. Biochem. pmid:6279585
Kono Y and Sugiura Y Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions. 1982 J. Biochem. pmid:6279586
Kono Y Aerobic oxidation of rifamycin SV to rifamycin S catalyzed by horseradish peroxidase. 1982 J. Biochem. pmid:7096316
Cui Y et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. 2001 J. Biol. Chem. pmid:11134001
Necula M et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. 2007 J. Biol. Chem. pmid:17284452
Vékey K et al. Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics. 1989 J. Chromatogr. pmid:2768398
Hartkoorn RC et al. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17643357
Beltrametti F et al. Antibiotic production improvement in the rare actinomycete Planobispora rosea by selection of mutants resistant to the aminoglycosides streptomycin and gentamycin and to rifamycin. 2006 J. Ind. Microbiol. Biotechnol. pmid:16331474
Caruso I et al. Multiple intra-articular treatment of rheumatoid arthritis: a randomized prospective study comparing rifamycin SV with pefloxacin. 1992 J. Int. Med. Res. pmid:1568518
Caruso I et al. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin. 1992 J. Int. Med. Res. pmid:1568521
Caruso I et al. Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. 1992 J. Int. Med. Res. pmid:1521673
Caruso I et al. Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis. 1993 Sep-Oct J. Int. Med. Res. pmid:8112482
Bruni L et al. Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. 1984 J. Int. Med. Res. pmid:6381169
Bruni L et al. Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. 1980 J. Int. Med. Res. pmid:6987112
van De Waterbeemd H et al. Property-based design: optimization of drug absorption and pharmacokinetics. 2001 J. Med. Chem. pmid:11311053
Traxler P et al. Hypolipidemic activity of rifamycin derivatives. 1990 J. Med. Chem. pmid:2299623
Cavalleri B et al. Synthesis and biological activity of some derivatives of rifamycin P. 1990 J. Med. Chem. pmid:2329569
Cricchio R and Tamborini G A new series of semisynthetic rifamycins. N derivatives of 4-amino-4-deoxyrifamycin SV. 1971 J. Med. Chem. pmid:4398855
Bellomo P et al. Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins. 1981 J. Med. Chem. pmid:7310806
Williams PG et al. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. 2007 J. Nat. Prod. pmid:17253854
van Montfoort JE et al. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. 1999 J. Pharmacol. Exp. Ther. pmid:10381771
Caruso I Rifamycin SV in the local treatment of synovitis. 1987 J. Rheumatol. pmid:3572924
Lindblad S et al. Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation. 1985 J. Rheumatol. pmid:4087269
Xiao-Chang F and Naganawa H 1H NMR analysis of R-75-1 substance. 1981 Jpn J Antibiot pmid:7289042
Alsdurf H et al. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. 2016 Lancet Infect Dis pmid:27522233
Murali Krishna PS et al. Effect of uracil on rifamycin SV production by Amycolatopsis mediterranei MV35R. 2000 Lett. Appl. Microbiol. pmid:10886619
Nagavalli M et al. Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei. 2015 Lett. Appl. Microbiol. pmid:25256628
Przybylski P et al. 13C and 15N CP/MAS, 1H-15N SCT CP/MAS and FTIR spectroscopy as tools for qualitative detection of the presence of zwitterionic and non-ionic forms of ansa-macrolide 3-formylrifamycin SV and its derivatives in solid state. 2014 Jan-Feb Magn Reson Chem pmid:24347399
Borsali E et al. [Ornithinimicrobium pekingense ocular infection]. 2011 Med Mal Infect pmid:21440391
Shao ZH et al. A preliminary study of the mechanism of nitrate-stimulated remarkable increase of rifamycin production in Amycolatopsis mediterranei U32 by RNA-seq. 2015 Microb. Cell Fact. pmid:26041361
Cottafava F et al. [Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV]. 1982 Minerva Pediatr. pmid:7070359
Vigliaroli E et al. Double pathological fracture of mandibula caused by actinomycotic osteomyelitis: a case report. 2010 Minerva Stomatol pmid:20940689
Arora SK Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV. 1983 Mol. Pharmacol. pmid:6865897
Qi F et al. Deciphering the late steps of rifamycin biosynthesis. 2018 Nat Commun pmid:29904078
Dechert-Schmitt AM et al. Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. 2014 Nat Prod Rep pmid:24514754
Woods LA et al. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. 2011 Nat. Chem. Biol. pmid:21873994
Okolicsanyi L et al. Influence of rifamycin SV on bile acid metabolism in rats. 1980 Naunyn Schmiedebergs Arch. Pharmacol. pmid:7422017
Wang EJ et al. Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. 2003 Pharm. Res. pmid:12739759
Swift B et al. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes. 2010 Pharm. Res. pmid:20652625
Evans SE et al. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. 2014 PLoS ONE pmid:24595451
Velichka D et al. Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review). 2010 Recent Pat Antiinfect Drug Discov pmid:19929844
Crance JM et al. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. 1997 Sep-Oct Res. Virol. pmid:9403935
Păunescu E et al. [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. 1982 Apr-Jun Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol pmid:6294806
Marchesoni A et al. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. 1993 Scand. J. Rheumatol. pmid:8356413
Spisani S et al. The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. 1982 Scand. J. Rheumatol. pmid:7089503
Zhao J et al. Preparation and application of rifamycin-capped (3-(2-O-β-cyclodextrin)-2-hydroxypropoxy)-propylsilyl-appended silica particles as chiral stationary phase for high-performance liquid chromatography. 2010 Talanta pmid:21035677
Furet Y et al. [Mixed hepatitis due to rifamycin SV. Apropos of a case]. 1986 Sep-Oct Therapie pmid:3810533
Freymuth F et al. [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. 1983 May-Jun Therapie pmid:6310814
Sayyed K et al. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. 2016 Toxicology pmid:27450509
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Karaivanov L et al. [Attempt at eliminating the multiple drug resistance of E. coli in pigs with enteritis using Rimactin]. 1980 Vet Med Nauki pmid:7015689
Senturk S and Temizel M Clinical efficacy of rifamycin SV combined with oxytetracycline in the treatment of caseous lymphadenitis in sheep. 2006 Vet. Rec. pmid:16905739
Sharma P et al. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. 2010 Xenobiotica pmid:19919292
Chiou WJ et al. In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. 2014 Xenobiotica pmid:23886114
Vogt E [Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema]. 1983 Z. Hautkr. pmid:6649743
Dekio S and Jidoi J Mechanism of coagulase production in Staphylococcus aureus Smith. 1983 Zentralbl Bakteriol Mikrobiol Hyg A pmid:6673416
Sha W [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. 2014 Zhonghua Jie He He Hu Xi Za Zhi pmid:25537407
Li Q et al. [Ocular syndromes in patients with neurobrucellosis]. 2015 Zhonghua Yan Ke Za Zhi pmid:26888270
Gao DZ [Determination of rifampin, rifamdin and rifocin concentrations in the CSF of 71 patients with tuberculous meningitis]. 1986 Zhonghua Yi Xue Za Zhi pmid:3094900